Results 61 to 70 of about 1,554,916 (325)

Racing against COVID-19: a vaccines strategy for Europe. Bruegel Policy Contribution Issue n˚7 | April 2020 [PDF]

, 2020
The fast development of vaccines is an essential part of the long-term solution to COVID-19, but vaccine development has high costs and carries the risk of high failure rates.
Veugelers, Reinhilde, Zachmann, Georg.
core   +1 more source

COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II

Psychological Medicine, 2020
Background Our aim was to estimate provisional willingness to receive a coronavirus 2019 (COVID-19) vaccine, identify predictive socio-demographic factors, and, principally, determine potential causes in order to guide information provision.
D. Freeman, B. S. Loe, A. Chadwick, Cristian Vaccari, Felicity Waite, L. Rosebrock, Lucy Jenner, Ariane Petit, S. Lewandowsky, S. Vanderslott, Stefania Innocenti, M. Larkin, Alberto Giubilini, Ly-Mee Yu, H. McShane, A. Pollard, S. Lambe   +16 more
semanticscholar   +1 more source

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.

Journal of the American Medical Association (JAMA), 2022
Importance Assessing COVID-19 vaccine performance against the rapidly spreading SARS-CoV-2 Omicron variant is critical to inform public health guidance.
Emma K. Accorsi, Amadea Britton, K. Fleming-Dutra, Zachary R. Smith, N. Shang, Gordana Derado, Joseph D. Miller, S. Schrag, J. Verani   +8 more
semanticscholar   +1 more source

Characterizing intentions to receive the COVID-19 vaccine among the general population in British Columbia based on their future intentions towards the seasonal influenza vaccine

Vaccine: X, 2022
Introduction: This study assessed the relationship between intention to receive a COVID-19 vaccine and intention to receive a seasonal influenza vaccine, as well as how intention to receive a COVID-19 vaccine has changed during the pandemic.
Bhawna Sharma, C. Sarai Racey, Amy Booth, Arianne Albert, Laurie W. Smith, Anna Gottschlich, David M. Goldfarb, Melanie C.M. Murray, Liisa A.M. Galea, Angela Kaida, Lori A. Brotto, Manish Sadarangani, Gina S. Ogilvie   +12 more
doaj   +1 more source

High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries

Vaccines, 2021
Vaccination could be an effective strategy for slowing the spread of the current coronavirus disease 2019 (COVID-19) pandemic. Vaccine hesitancy could pose a serious problem for COVID-19 prevention, due to the spread of misinformation surrounding the ...
Malik Sallam, D. Dababseh, H. Eid, Kholoud Al-Mahzoum, A. Al-Haidar, D. Taim, A. Yaseen, N. Ababneh, F. Bakri, A. Mahafzah   +9 more
semanticscholar   +1 more source

The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic

Human Vaccines & Immunotherapeutics, 2022
Background Addressing COVID-19 vaccine hesitancy is key to ending the COVID-19 pandemic. Communication and media environments are potential drivers of vaccine hesitancy.
Hui Ouyang, Xiaohan Ma, Xiang Wu
doaj   +1 more source

Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature [PDF]

, 2020
In March 2020, the World Health Organization declared the spread of SARS-CoV-2 a global pandemic. To date, coronavirus disease-2019 (COVID-19) has spread to over 200 countries, leading to over 1.6 million cases and over 99,000 deaths. Given that there is
Aly, Besma, Baron, David A., Blodget, Emily, Hashemi, Areio, Kouyoumjian, Sarkis, Musa, Arif, Pendi, Kasim, Stevens, Susan, Warbasse, Elizabeth, Yousif, Jenna   +9 more
core  

Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia

Frontiers in Public Health, 2020
Introduction: Several vaccine candidates are being clinically tested in response to the 2019 coronavirus disease (COVID-19) pandemic. This study was conducted to assess the acceptance of a 50 or 95% effective COVID-19 vaccine, when it becomes available ...
H. Harapan, A. Wagner, Amanda Yufika, Wira Winardi, Samsul Anwar, Alex Kurniawan Gan, A. M. Setiawan, Y. Rajamoorthy, Hizir Sofyan, M. Mudatsir   +9 more
semanticscholar   +1 more source

Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021

Nature Communications, 2022
The COVID-19 pandemic continues to impact daily life, including health system operations, despite the availability of vaccines that are effective in greatly reducing the risks of death and severe disease.
J. Lazarus, K. Wyka, Trenton M. White, C. Picchio, Kenneth H. Rabin, S. Ratzan, J. Parsons Leigh, Jia Hu, A. El-Mohandes   +8 more
semanticscholar   +1 more source

Sociodemographic Determinants of COVID-19 Vaccine Hesitancy, Fear of Infection, and Protection Self-Efficacy

Journal of Primary Care & Community Health, 2021
Objectives: Arkansas COVID-19 vaccine uptake has been lower than the national average. This study examined associations between sociodemographic factors and COVID-19 vaccine hesitancy, fear of infection, and protection self-efficacy.
Pearl A. McElfish, Don E. Willis, Sumit K. Shah, Keneshia Bryant-Moore, Martha O. Rojo, James P. Selig   +5 more
doaj   +1 more source